-->

Tech Seeker (TS)

GlaxoSmithKline plc (AKA:Glaxo Wellcome plc)
Profile last edited on: 3/11/2022

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
TS Type
Major Corporation
Status
Year Founded
1935
Last Involved Year
2021

Key People / Management

  Emma N Walmsley -- CEO & Director

  Andrew Philip Witty -- Former President

  Govind M Agrawal -- VP, Worldwide Business De

  Patricia Audet --

  Mary S Barnette --

  Frank C Barone --

  Barbara K Beck -- Manager, Third Party Mana

  Leslie Boyd -- Vice President, Worldwide Business Development Scientific Licensing

  Erin Brubaker -- Vice President, Worldwide Business Development Alliance Management

  Anna Marie Camoratto -- Manager, Technical Evalua

  Alejandro Canakis --

  John L Cantello -- Technology Licensing

  Wenji Chen --

  Kyle H Chenet -- Manager, Business Develop

  Geoffrey D Clarke --

  Gregg J Davis -- Director, Commercial Alli

  David P DeMagistris --

  Jon Ellis -- Vice President, Business Development Platform Technology & Science and Biopharmaceuticals R&D

  James E Foley -- Vice President, Business

  Kevin V Foley -- Director, Worldwide Busin

  Bali Gangadharan -- Associate Director

  Denise Gatling --

  Thomas T Hane -- Director, Deal Structurin

  Lisa Y Hanger --

  R Wayne Hendren -- Director, Technical Evalu

  J Paul Hieble --

  A Jacqueline Hunter -- SVP Science Environment D

  Jeb Keiper --

  Zolton Kerekes -- Director, Investments

  Karen L Key -- Director, Business Develo

  Patrick J Klepcyk --

  William Koch -- Consumer Healthcare Business Development

  James R Lang --

  James R Lang -- Director, Business Develo

  Charlotte A Lemmonds --

  Gail Martin --

  Damien McDevitt --

  Richard McGregor -- Director, Open Innovation

  Brian P McVeigh --

  Richard W Miller -- U.S. Academic Liaison Man

  Jo Kelley Mohr --

  Jose A Naranjo -- Product Manager Business

  David Paterson -- Director, US Academic Lia

  Dhiraj Pathak --

  Walter C Plunkett -- Director, Global Business

  Terence G Porter --

  Terence G Porter -- Director, Technology Lice

  Richard C Proctor -- Director, Business Develo

  Robert H Ramsey-Lefevere --

  Vidette Rouse -- Manager, Commercial Allia

  Susan Russell --

  Gulzar S Sandhu -- Director, Technical Licen

  David L Saussy -- Director, Scientific Lice

  Richard J Shimizu --

  Lee Shorter -- Director, Disruptive Technology Seekers, Platform Technologies and Science

  Catherine A Sohn --

  Scott D Sorensen --

  Theodore C Spaulding --

  Michael T Stocum -- Director, Business Develo

  Diane E Sullivan -- Director, Worldwide Busin

  Steve Y Tan --

  John P Throup --

  Ian Tomlinson -- Senior Vice President, Worldwide Business Development and Biopharmaceuticals R&D

  Deborah G Weis --

  Phil E West --

  Greg Westerbeck -- Director, Worldwide Busin

  Timothy D Westfall --

  Raymond L Willis -- Business Development

Location Information

980 Great West Road
Brentford, GB TW8 9GS
   (442) 089-909000
   www.gsk.com

Public Profile

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
UK
Employment
99,096
Revenue
$41.4B
Public/Private
Publicly Traded
Stock Info
NYSE : GSK
Received SBIR $$
No

SBIR firms in the news

There are no news available.